ARCHIVES

In Phase II Study, NKTR-102 Shows Objective Response

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Robert Weinburger, Ernst Wynder Win Top Milken Awards

November 2, 1990

New Understanding of drug Resistance Exciting Revolution

September 17, 1982

AACR Honorary Memberships; ASCO Awards

July 20, 1990

NIH Grants: NIH Can’t Award Funds To Schools That Prevent Military Recruiting

September 12, 1997

ADT May Increase Risk Of Cardio Events In Prostate Cancer Patients

February 5, 2010

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014